Good afternoon Vancouver 🌞🏔️ It’s 2026 and melanoma data continue to move in TIL 🏋️♀️
@drbetofmdphd.bsky.social discusses 10 year melanoma survival data for patients who have experienced complete response with earlier versions of TIL #MovingTheGoalPosts #CMC26 @stanford-cancer.bsky.social
